Download the Case Study
Solving Operational Complexity in Early Phase Retinal Trials
Solving Operational Complexity in Early Phase Retinal Trials
Solving Operational Complexity in Early Phase Retinal Trials
Inherited retinal diseases present unique clinical and operational challenges, particularly in gene therapy studies, where genetically defined patient populations and complex safety oversight are required.
The following case study highlights key operational strategies implemented by Medpace to support efficient cohort management, proactive safety monitoring, and strong site engagement. These approaches enabled successful recruitment of a genetically defined early phase cohort of 20+ participants across multiple specialized sites, demonstrating effective enrollment within a highly selective patient population while providing insights applicable to future ophthalmology programs.
Leading Ophthalmology CRO
Drive the successful execution of Phase I-IV ophthalmology clinical trials through a partner with strong communication, coupled with early planning and experience collaborating with global regulatory authorities. Sponsors from emerging biotechs to global pharmaceutical companies have trusted Medpace for over 30 years to lead their ophthalmology development across a wide range of indications, including but not limited to Age-Related Macular Degeneration, Inherited Retinal Disease, Cataracts, Glaucoma, Cornea, Diabetic Macular Edema, and Natural History Studies.